Literature DB >> 35811100

Generation of sex-reversed female clonal mice via CRISPR/Cas9-mediated Y chromosome deletion in male embryonic stem cells.

Yiren Qin1, Fuqiang Geng2, Duancheng Wen3.   

Abstract

Mice derived entirely from embryonic stem (ES) cells can be generated through tetraploid complementation. Although XY male ES cell lines are commonly used in this system, occasionally, monosomic XO female mice are produced through spontaneous Y chromosome loss. Here, we describe an efficient method to obtain monosomic XO ES cells by CRISPR/Cas9-mediated deletion of the Y chromosome allowing generation of female clonal mice by tetraploid complementation. The monosomic XO female mice are viable and able to produce normal male and female offspring. Direct generation of clonal mice in both sexes can significantly accelerate the production of complex genetically modified mouse models.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR/Cas9; Monosomic XO female mice; Mouse embryonic stem cells; Tetraploid complementation; Y chromosome deletion

Mesh:

Year:  2022        PMID: 35811100      PMCID: PMC9280658          DOI: 10.1016/bs.mcb.2022.02.015

Source DB:  PubMed          Journal:  Methods Cell Biol        ISSN: 0091-679X            Impact factor:   1.829


  14 in total

1.  Male and female mice derived from the same embryonic stem cell clone by tetraploid embryo complementation.

Authors:  Kevin Eggan; Anja Rode; Isabell Jentsch; Caroline Samuel; Thomas Hennek; Hartmut Tintrup; Branko Zevnik; Jennifer Erwin; Janet Loring; Laurie Jackson-Grusby; Michael R Speicher; Ralf Kuehn; Rudolf Jaenisch
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

2.  Establishment in culture of pluripotential cells from mouse embryos.

Authors:  M J Evans; M H Kaufman
Journal:  Nature       Date:  1981-07-09       Impact factor: 49.962

3.  Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation.

Authors:  K Eggan; H Akutsu; J Loring; L Jackson-Grusby; M Klemm; W M Rideout; R Yanagimachi; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

4.  Sfrp1 and Sfrp2 are required for normal male sexual development in mice.

Authors:  Nick Warr; Pam Siggers; Debora Bogani; Rachel Brixey; Laura Pastorelli; Laura Yates; Charlotte H Dean; Sara Wells; Wataru Satoh; Akihiko Shimono; Andy Greenfield
Journal:  Dev Biol       Date:  2008-12-07       Impact factor: 3.582

5.  Developmental and adult phenotyping directly from mutant embryonic stem cells.

Authors:  Sophia H L George; Marina Gertsenstein; Kristina Vintersten; Ella Korets-Smith; John Murphy; Mary E Stevens; Jody J Haigh; Andras Nagy
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-02       Impact factor: 11.205

6.  The ground state of embryonic stem cell self-renewal.

Authors:  Qi-Long Ying; Jason Wray; Jennifer Nichols; Laura Batlle-Morera; Bradley Doble; James Woodgett; Philip Cohen; Austin Smith
Journal:  Nature       Date:  2008-05-22       Impact factor: 49.962

7.  Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins.

Authors:  Sojung Kim; Daesik Kim; Seung Woo Cho; Jungeun Kim; Jin-Soo Kim
Journal:  Genome Res       Date:  2014-04-02       Impact factor: 9.043

8.  CRISPR/Cas9-mediated targeted chromosome elimination.

Authors:  Erwei Zuo; Xiaona Huo; Xuan Yao; Xinde Hu; Yidi Sun; Jianhang Yin; Bingbing He; Xing Wang; Linyu Shi; Jie Ping; Yu Wei; Wenqin Ying; Wei Wei; Wenjia Liu; Cheng Tang; Yixue Li; Jiazhi Hu; Hui Yang
Journal:  Genome Biol       Date:  2017-11-24       Impact factor: 13.583

9.  Completely ES cell-derived mice produced by tetraploid complementation using inner cell mass (ICM) deficient blastocysts.

Authors:  Duancheng Wen; Nestor Saiz; Zev Rosenwaks; Anna-Katerina Hadjantonakis; Shahin Rafii
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

10.  High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.

Authors:  Benjamin P Kleinstiver; Vikram Pattanayak; Michelle S Prew; Shengdar Q Tsai; Nhu T Nguyen; Zongli Zheng; J Keith Joung
Journal:  Nature       Date:  2016-01-06       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.